Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients
We report our experience with the incidence of adverse events during the use of Stimate brand intranasal desmopressin acetate (IN DDAVP) for patients with haemophilia A (HA) or von Willebrand disease (vWD) after noting two severe adverse events in one adult patient. All patients with documented vWD (type 1 or 2 A) or haemophilia A (mild, moderate or symptomatic carrier) from the Emory Comprehensive Hemophilia Center who had IN DDAVP challenge testing or were using Stimate for treatment of bleeding were evaluated for adverse events by patient report or nursing observation of clinical signs and symptoms. Forty patients were studied. Sixty-eight per cent (27/40) experienced clinical signs and/or symptoms. The majority of these symptoms were mild, however several patients reported moderate to severe side-effects and one adult patient required medical intervention for symptomatic hyponatraemia. In our experience, two-thirds of patients tested experienced adverse signs and/or symptoms with the use of Stimate; considerably higher than that reported from preliminary results in the literature. Young age did not correlate positively with adverse reactions. Severe adverse events requiring medical intervention were rare, however symptoms s...Continue Reading
1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases
Treatment of hemophilia A and von Willebrand's disease patients with an intranasal dripping of DDAVP
Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)
Generalized tonic-clonic seizures in adult patients following intravenous administration of desmopressin
DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study
Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy
epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England
Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype
Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres
Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature
Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives
Syndrome of inappropriate antidiuretic hormone secretion associated with coproporphyria: case report and review of literature.
Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders
Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery
Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study
Efficacy and Safety of half-dose desmopressin for bleeding prophylaxis in bleeding disorder patients undergoing predominantly low to moderate risk invasive procedures
Management of large volume liposuction in lipedema patients with von Willebrand disease: A systematic review and treatment algorithm.
Antipsychotic-Induced Weight Gain
Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.
Blood Clotting Disorders
Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.